17.92
Schlusskurs vom Vortag:
$18.37
Offen:
$18.5
24-Stunden-Volumen:
95,701
Relative Volume:
0.58
Marktkapitalisierung:
$459.50M
Einnahmen:
$243.30M
Nettoeinkommen (Verlust:
$-39.68M
KGV:
-10.65
EPS:
-1.6825
Netto-Cashflow:
$-14.64M
1W Leistung:
-1.65%
1M Leistung:
+10.75%
6M Leistung:
-3.55%
1J Leistung:
-13.92%
Orthopediatrics Corp Stock (KIDS) Company Profile
Firmenname
Orthopediatrics Corp
Sektor
Branche
Telefon
574-268-6379
Adresse
2850 FRONTIER DRIVE, WARSAW, IN
Compare KIDS vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
KIDS
Orthopediatrics Corp
|
17.89 | 471.83M | 243.30M | -39.68M | -14.64M | -1.6825 |
|
ABT
Abbott Laboratories
|
86.66 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
312.95 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
77.59 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
57.66 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
87.56 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Orthopediatrics Corp Stock (KIDS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-27 | Eingeleitet | TD Cowen | Buy |
| 2025-12-10 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-04-07 | Eingeleitet | Lake Street | Buy |
| 2024-01-25 | Herabstufung | Truist | Buy → Hold |
| 2021-06-14 | Bestätigt | Needham | Buy |
| 2020-04-02 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-06-19 | Eingeleitet | Needham | Buy |
| 2019-02-20 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2018-07-05 | Bestätigt | Piper Jaffray | Overweight |
Alle ansehen
Orthopediatrics Corp Aktie (KIDS) Neueste Nachrichten
OrthoPediatrics Corp. (KIDS) Q1 2026 Earnings: Narrower-Than-Expected Loss Surprises MarketCost Structure Review - Newser
OrthoPediatrics Corp. (KIDS) Holds Steady as Trading Volume Remains SubduedPrice Gap Fill - Newser
OrthoPediatrics Corp stock (US68735M1027): pediatric specialist reports Q1 2025 growth and raised ou - AD HOC NEWS
Orthopediatrics Corp Raises Outlook Amid EBITDA Turnaround - TipRanks
OrthoPediatrics Corp. (NASDAQ:KIDS) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
OrthoPediatrics Corp stock (US68735M1027): pediatric orthopedics specialist updates investors after - AD HOC NEWS
KIDS Stock Price, Quote & Chart | ORTHOPEDIATRICS CORP (NASDAQ:KIDS) - ChartMill
Canaccord Genuity initiates coverage of OrthoPediatrics (KIDS) with buy recommendation - MSN
Number of shareholders of OrthoPediatrics Corp. – NASDAQ:KIDS - TradingView
Number of shareholders of OrthoPediatrics Corp. – LS:A2JAAV - TradingView
OrthoPediatrics (NASDAQ: KIDS) counsel gifts 2,479 Common Stock shares - Stock Titan
OrthoPediatrics stock (US68735M1027): Pediatric orthopedic device maker trades near resistance - AD HOC NEWS
Minot Light Capital Partners Q1 2026 Investor Letter - HarianBasis.co
Is the Selloff in OrthoPediatrics Corp. (KIDS) Creating a Buying Opportunity? - Insider Monkey
kids4q23pre-announce2024.htm - SEC.gov
KIDS SEC FilingsOrthopedia 10-K, 10-Q, 8-K Forms - Stock Titan
OrthoPediatrics Corp. (KIDS) Stock Analysis: Navigating a 40% Potential Upside with Strategic Growth - DirectorsTalk Interviews
KIDS (OrthoPediatrics) Q1 results exceed expectations with 15.4% revenue growth, stock jumps 2.63%.Guidance Upgrade Report - Newser
OrthoPediatrics (KIDS) Q1 2026 Earnings Transcript - AOL.com
Earnings call transcript: Orthopediatrics beats Q1 2026 earnings forecast By Investing.com - Investing.com Nigeria
Earnings call transcript: Orthopediatrics beats Q1 2026 earnings forecast - Investing.com
OrthoPediatrics (KIDS) Q1 Losses Challenge Bullish Margin Narratives Despite 11.1% Revenue Growth - Sahm
(KIDS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
OrthoPediatrics raises 2026 revenue outlook to $263M-$267M while targeting free cash flow breakeven - MSN
Orthopediatrics Corp Earnings Call Shows Profitable Momentum - TipRanks
OrthoPediatrics (NASDAQ: KIDS) posts 13% Q1 revenue rise but remains unprofitable - Stock Titan
OrthoPediatrics (NASDAQ:KIDS) Given "Buy" Rating at BTIG Research - MarketBeat
OrthoPediatrics (NASDAQ:KIDS) Announces Quarterly Earnings Results - MarketBeat
Earnings call transcript: Orthopediatrics Q1 2026 beats forecasts, stock rises By Investing.com - Investing.com India
OrthoPediatrics Corp. Q1 2026 Earnings Call Summary - Yahoo Finance
OrthoPediatrics Q1 Earnings Call Highlights - MarketBeat
OrthoPediatrics Corp. (NASDAQ:KIDS) Surges After-Hours on Q1 Earnings Beat and Raised Full-Year Guidance - ChartMill
OrthoPediatrics (KIDS) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
OrthoPediatrics (KIDS) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
Earnings call transcript: Orthopediatrics Q1 2026 beats forecasts, stock rises - Investing.com
OrthoPediatrics Q1 2026 Earnings Call: Complete Transcript - Benzinga
OrthoPediatrics: Q1 Earnings Snapshot - LPHeraldDispatch.com
OrthoPediatrics Corp reports results for the quarter ended March 31Earnings Summary - TradingView
OrthoPediatrics launches spinal traction system for children By Investing.com - Investing.com South Africa
OrthoPediatrics launches spinal traction system for children - Investing.com
OrthoPediatrics Corp. Reports First Quarter 2026 Financial Results and Increases 2026 Financial Guidance - The Manila Times
OrthoPediatrics Expands Specialty Bracing Portfolio with TRAXIO Halo Gravity Traction System - The Manila Times
OrthoPediatrics (KIDS) sees 2026 growth to ~$265M revenue and positive EBITDA - Stock Titan
OrthoPediatrics (NASDAQ: KIDS) lifts 2026 outlook after strong Q1 - Stock Titan
New hospital device uses weights to gradually realign children's spines - Stock Titan
Finanzdaten der Orthopediatrics Corp-Aktie (KIDS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Orthopediatrics Corp-Aktie (KIDS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hite Fred | COO and CFO |
Mar 16 '26 |
Sale |
17.25 |
12,993 |
224,129 |
277,477 |
| Bailey David R | President and CEO |
Mar 16 '26 |
Sale |
17.25 |
19,535 |
336,979 |
298,020 |
| Odle Gregory A | President of Scoliosis |
Mar 16 '26 |
Sale |
17.25 |
8,433 |
145,469 |
187,735 |
| Gerritzen Daniel J | General Counsel and Secretary |
Mar 16 '26 |
Sale |
17.25 |
8,614 |
148,592 |
149,533 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):